HKMPF (Hikma Pharmaceuticals) Dividend Payout Ratio: 0.34 (As of Dec. 2025) — 17% Above Median


HKMPF Hikma Pharmaceuticals PLC HKMPF
82 GF Score
Price $20.12
GF Value $26.53
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Hikma Pharmaceuticals Dividend Payout Ratio?

Hikma Pharmaceuticals HKMPF +4.28% 82 Dividend Payout Ratio is 0.34 as of Dec. 2025, which is 17% above its 10-year median of 0.29. GuruFocus rates HKMPF with a GF Score™ of 82/100 and a GF Value™ of $26.53 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 444 Drug Manufacturers companies, Hikma Pharmaceuticals ranks better than 51.35% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Hikma Pharmaceuticals's Dividend Payout Ratio for the months ended in Dec. 2025 was 0.34.

The historical rank and industry rank for Hikma Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:

HKMPF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.25   Med: 0.29   Max: 0.38
Current: 0.37

During the past 13 years, the highest Dividend Payout Ratio of Hikma Pharmaceuticals was 0.38. The lowest was 0.25. And the median was 0.29.

HKMPF's Dividend Payout Ratio is ranked better than
51.35% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.375 vs HKMPF: 0.37

As of today (2026-06-30), the Dividend Yield % of Hikma Pharmaceuticals is 4.17%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Hikma Pharmaceuticals was 5.20%. The lowest was 0.65%. And the median was 1.95%.

Hikma Pharmaceuticals's Dividends per Share for the months ended in Dec. 2025 was $0.36.

During the past 12 months, Hikma Pharmaceuticals's average Dividends Per Share Growth Rate was 1.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 13.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 14.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 12.80% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hikma Pharmaceuticals was 38.40% per year. The lowest was 8.90% per year. And the median was 15.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Hikma Pharmaceuticals (OTCPK:HKMPF) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Hikma Pharmaceuticals Dividend Payout Ratio Related Terms

Hikma Pharmaceuticals Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Hikma Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hikma Pharmaceuticals Dividend Payout Ratio Chart

Hikma Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.29 0.38 0.36 0.37

Hikma Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.37 0.34 0.40 0.34

HKMPF vs ZTS, UTHR, VTRS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hikma Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hikma Pharmaceuticals Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hikma Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Hikma Pharmaceuticals's Dividend Payout Ratio falls into.


HKMPF
82GF Score
Hikma Pharmaceuticals PLC HKMPF
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hikma Pharmaceuticals Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Hikma Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0.84/ 2.26
=0.37

Hikma Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0.36/ 1.05
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.34 mean?
Hikma Pharmaceuticals (HKMPF) has a Dividend Payout Ratio of 0.34 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Hikma Pharmaceuticals and its competitors. This is 17% above median its historical median of 0.29. Over the past decade, Hikma Pharmaceuticals' Dividend Payout Ratio has ranged from 0.25 to 0.38. According to the industry distribution chart, Hikma Pharmaceuticals ranks #216 out of 444 companies in the Drug Manufacturers industry, placing it in the top 48.6%.
Is Hikma Pharmaceuticals' Dividend Payout Ratio too high?
Hikma Pharmaceuticals' current Dividend Payout Ratio of 0.34 is 17% above median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 0.38. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Hikma Pharmaceuticals' value of 0.34 is 9.3% below this industry median. Based on the distribution chart, Hikma Pharmaceuticals ranks #216 out of 444 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hikma Pharmaceuticals has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hikma Pharmaceuticals' Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hikma Pharmaceuticals ranks #216 out of 444 companies for Dividend Payout Ratio. This puts Hikma Pharmaceuticals in the upper half of its industry. The industry median Dividend Payout Ratio is 0.38. Hikma Pharmaceuticals' value of 0.34 is 9.3% below this benchmark. Historically, Hikma Pharmaceuticals' own Dividend Payout Ratio has ranged from 0.25 to 0.38 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 0.38, Hikma Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hikma Pharmaceuticals's current Dividend Payout Ratio of 0.34 is 9.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Hikma Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hikma Pharmaceuticals's current Dividend Payout Ratio is 0.34, which is 17% above median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hikma Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Hikma Pharmaceuticals (HKMPF) is currently considered Modestly Undervalued. The stock's GF Value™ is $26.53, compared to a current price of $20.12 — trading 24.2% below its estimated fair value. The current Dividend Payout Ratio is 0.34, which is 17% above median its 10-year median of 0.29 and 9.3% below the Drug Manufacturers industry median of 0.38. Hikma Pharmaceuticals' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Hikma Pharmaceuticals (HKMPF), the current Dividend Payout Ratio is 0.34 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hikma Pharmaceuticals (HKMPF) Overvalued in 2026?

Based on GuruFocus' analysis, Hikma Pharmaceuticals stock appears to be undervalued. The current stock price of $20.12 is trading 24.2% below its estimated GF Value™ of $26.53. GuruFocus considers Hikma Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for HKMPF:

  • Dividend Payout Ratio: 0.34 (17% above median its 10-year median of 0.29)
  • GF Value™: $26.53 vs. price of $20.12 (24.2% below fair value)
  • GF Score™: 82/100 with 5 warning signs
  • Industry Position: 9.3% below the Drug Manufacturers median (#216 of 444)

No single metric tells the full story. See the HKMPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hikma Pharmaceuticals Business Description

Address 10 Portman Square, London, GBR, W1H 6AZ
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority of the company's revenue is generated from its injectables segment, which supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue-generating market, followed by the Middle East and North Africa, the United Kingdom, Europe, and the rest of the world.
82GF Score

Get the complete analysis for HKMPF

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.12
Price
$26.53
GF Value